Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics • Transportation, E-Commerce & Mechanical Systems
7 pending office actions • 6 clients • 7 examiners • 7 art units • 0 of 7 (0%) have an AI response strategy ready
HOGAN LOVELLS US LLP has 7 pending office actions in Biotechnology & Pharmaceuticals. Its career record includes 6276 applications, providing a substantial historical base for life sciences prosecution. The pending docket identifies current examination matters within that broader filing history.
The resolved allowance rate is 83.41%, and allowed matters have required an average of 3.3 office actions. The allowance rate measures resolved outcomes, while the action average describes the examination exchanges associated with allowance. Practitioners can use the two figures separately when assessing results and planning response resources.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (57%) |
| §112 only | 1 (14%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHEN, FRANK S | 1 | 82.3% | +8.4% |
| ABULABAN, ABDALLAH | 1 | 71.3% | +13.6% |
| PATEL, NEEL G | 1 | 62.1% | +34.6% |
| LEGESSE, HENOK D | 1 | 86.5% | +2.2% |
| SINGER, DAVID L | 1 | 69.1% | +42.1% |
| ROZOF, TIMOTHY R | 1 | 72.7% | +23.3% |
| ABBAS, ABDULRAHMAN MUSTAFA | 1 | 51.6% | +29.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18235728 | MODULAR STACKING THERMAL PRINTERS | LEGESSE, HENOK D | 127d overdue |
| 19004952 | AUGMENTED REALITY TRAFFIC ADVISOR SYSTEM AND METHOD | CHEN, FRANK S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17951342 | ALDOSE REDUCTASE INHIBITORS FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME, ACUTE LUNG INFLAMMATION/INJURY, CARDIAC INJURY AND ANTI-VIRAL THERAPY | ROZOF, TIMOTHY R | 76d |
| 18540511 | CHARACTERIZATION SYSTEM AND METHOD FOR CEMENT EVALUATION THROUGH-TUBING | ABULABAN, ABDALLAH | — |
| 18547108 | SYSTEM AND METHOD FOR HYDRATE PRODUCTION | PATEL, NEEL G | — |
| 18207978 | PRECISE BEARING MEASUREMENT DEVICE | SINGER, DAVID L | — |
| 17048491 | ANTIFUNGAL FORMULATIONS FOR PULMONARY ADMINISTRATION COMPRISING ITRACONAZOLE | ABBAS, ABDULRAHMAN MUSTAFA | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Baker Hughes | 2 |
| WHELEN ENGINEERING COMPANY INC. | 1 |
| Kodak | 1 |
| Kama-Tech (Hk) Limited | 1 |
| Applied Therapeutics | 1 |
| Pulmatrix Operating Company, Inc. | 1 |
| Art Unit | Apps |
|---|---|
| 2611 | 1 |
| 3645 | 1 |
| 3676 | 1 |
| 2853 | 1 |
| 2855 | 1 |
| 1625 | 1 |
| 1612 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19004952 | AUGMENTED REALITY TRAFFIC ADVISOR SYSTEM AND METHOD | Whelen Engineering Company, Inc. | CHEN, FRANK S | 2611 | §102§103Other | Non-Final OA | — | Pending | Dec 30, 2024 |
| 18540511 | CHARACTERIZATION SYSTEM AND METHOD FOR CEMENT EVALUATION THROUGH-TUBING | BAKER HUGHES OILFIELD OPERATIONS LLC | ABULABAN, ABDALLAH | 3645 | §103Other | Final Rejection | — | Pending | Dec 14, 2023 |
| 18547108 | SYSTEM AND METHOD FOR HYDRATE PRODUCTION | BAKER HUGHES OILFIELD OPERATIONS LLC | PATEL, NEEL G | 3676 | §103 | Final Rejection | — | Pending | Aug 18, 2023 |
| 18235728 | MODULAR STACKING THERMAL PRINTERS | Kodak Alaris Inc. | LEGESSE, HENOK D | 2853 | §102§103§112 | Non-Final OA | 127d overdue | Pending | Aug 18, 2023 |
| 18207978 | PRECISE BEARING MEASUREMENT DEVICE | Kama-Tech (Hk) Limited | SINGER, DAVID L | 2855 | §103 | Non-Final OA | — | Pending | Jun 09, 2023 |
| 17951342 | ALDOSE REDUCTASE INHIBITORS FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME, ACUTE LUNG INFLAMMATION/INJURY, CARDIAC INJURY AND ANTI-VIRAL THERAPY | Applied Therapeutics, Inc. | ROZOF, TIMOTHY R | 1625 | §112 | Non-Final OA | 76d | Pending | Sep 23, 2022 |
| 17048491 | ANTIFUNGAL FORMULATIONS FOR PULMONARY ADMINISTRATION COMPRISING ITRACONAZOLE | Pulmatrix Operating Company, Inc. | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | §103 | Final Rejection | — | Pending | Oct 16, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial83.4% of resolved applications prosecuted by Hogan Lovells US LLP were allowed, across 6,276 applications in USPTO records.
3.30 office actions per allowed application on average.
7 pending office actions as of October 2026, for 6 clients, before 7 examiners in 7 art units.
